Fungal Infections Associated with Contaminated Methylprednisolone in Tennessee
NEJM 367:2194-2203, Kainer, M.,et al, 2012
Acute severe visual loss and a brainstem mass
Lancet 380:1790, Meleth, A.,et al, 2012
Alemtuzumab for Multiples Sclerosis: Who and When to treat?
Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012
Subdural empyema in bacterial meningitis
Neurol 79:2133-2139, Jim, K.,et al, 2012
Low-Molecular-Weight Heparin and Early Neurologic Deterioration in Acute Stroke Caused by Large Artery Occlusive Disease
Arch Neurol 69:1454-1460, Wang, Q.,et al, 2012
Multimodal Imaging of Reversible Cerebral Vasoconstriction Syndrome: A Series of 6 Cases
AJNR 33:1403-1410, Marder, C.P.,et al, 2012
A 48-year old woman with Recurrent Headache, Transient Neurologic Symptoms, and CSF Pleocytosis
Neurol 79e59-e62, Kerasnoudis, A.,et al, 2012
Clinical Reasoning: A Young Man with Reversible Paralysis, Cerebral White Matter Lesions, and Peripheral Neuropathy
Neurol 79: e70-e72, Zhong, L.,et al, 2012
Hyperosmolar Therapy for Raised Intracranial Pressure
NEJM 367:746-752, Ropper, A.H., 2012
Adult Primary Central Nervous System Vasculitis
Lancet 380:767-777, Salvarani, C.,et al, 2012
Spectrum of Transient Focal Neurological Episodes in Cerebral Amyloid Angiopathy
Stroke 43:2324-2330, Charidimou, A.,et al, 2012
Hemostatic Therapy Should be Used for Acute Treatment of Anticoagulation-Related Intracerebral Hemorrhage
Stroke 43:2535-2536,2539, Diringer, M. & Zazulia, A.R., 2012
Hemostatic Therapy Should not be Used for Acute Treatment of Anticoagulation-Related Intracerebral Hemorrhage
Stroke 43:2537-2538,2539, Stapf, C., 2012
Morvan Syndrome: Clinical and Serological Observations in 29 Cases
Ann Neurol 72:241-255, Irani, S.R.,et al, 2012
Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients with Multiple Sclerosis
Arch Neurol 69:1259-1269, Radue, E.W.,et al, 2012
Clinicopathologic Conference, Acute Ischemic Stroke due to Basilar Artery Embolism. Patent Foramen Ovale
NEJM 367:1450-1460, Case 31-2012, 2012
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
NEJM 367:1098-1106,1149, Gold, R.,et al, 2012
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
NEJM 367:1087-1097,1149, Fox, R.J.,et al, 2012
Solitaire Flow Restoration Device Versus the Merci Retriever in Patients with Acute Ischaemic Stroke (SWIFT): a Randomised, Parallel-Group, Non-Inferiority Trial
Lancet 380:1241-1249,1208, Saver, J.L.,et al, 2012
Neurologic Manifestations of E Coli infection - induced Hemolytic-Uremic Syndrome in Adults
Neurol 79:1466-1473, Weissenborn, K.,et al, 2012
Brain Metastases from Hepatocellular Carcinoma: Clinical Features and Prognostic Factors
BMC Cancer 12:49, Jiang, X.,et al, 2012
Expanding the Clinical, Radiological and Neuropathological Phenotype of Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS)
JNNP 83:15-22, Simon, N.G.,et al, 2012
Cerebrovascular Complications of Neurocysticercosis
The Neurologist 18:17-22, Marquez, J.M. and Arauz, A., 2012
Cerebral Amyloid Angiopathy
eMedicine, Jan, Menon, R.S., 2012
Sporadic Cerebral Amyloid Angiopathy Revisited: Recent Insights Into Pathophysiology and Clinical Spectrum
JNNP 83:124-137, Charidimou,A.,et al, 2012
Idiopathic Thoracic Spinal Cord Herniation: Retrospective Analysis Supporting a Mechanism of Diskogenic Dural Injury and Subsequent Tamponade
AJNR 33:52-56, Brus-Ramer,M. and Dillon,W.P., 2012
Self-Monitoring of Oral Anticoagulation: Systematic Review and Meta-Analysis of Individual Patient Data
Lancet 379:322-34, Heneghan,C., 2012
Low-Molecular-Weight Heparin Versus Aspirin for Acute Ischemic Stroke with Large Artery Occlusive Disease
Stroke 43:346-349,293, Wang,Q.S,et al, 2012
Clinical Reasoning: A 33-year-old Woman with Severe Postpartum Occipital Headaches
Neurol 78:366-369, Maalouf,N. and Harik,S.I., 2012
Characteristics of Intravascular Large B-Cell Lymphoma on Cerebral MR Imaging
AJNR 33:292-296, Yamamoto,A.,et al, 2012
Association Between Immediate Initiation of Intramuscular Interferon Beta-1a at the Time of a Clinically Isolated Syndrome and Long-term Outcomes
Arch Neurol 69:183-190, Kinkel,R.P.,et al, 2012
Natalizumab-Associated PML Identified in the Presymptomatic Phase Using MRI Surveillance
Neurol 78:507-508, Blair,N.F.,et al, 2012
The Autosomal Recessive Cerebellar Ataxias
NEJM 366:636-646, Anheim,M.,et al, 2012
The Argatroban and Tissue-Type Plasminogen Activator Stroke Study
Stroke 43:770-775,623, Barreto,A.D.,et al, 2012
Variable Presentations of Postpartum Angiopathy
Stroke 43:670-676, Fugate,J.E.,et al, 2012
Inflammatory Myopathies with Anti-Ku Antibodies
Medicine 91:95-102, Rigolet,A.,et al, 2012
Cogan Syndrome An Analysis of Reported Neurological Manifestations
The Neurologist 18:55-63, Antonios,N. and Silliman,S., 2012
Clinicopathologic Conference,Brain Abscess due to Toxoplasma and Advanced HIV Infection
NEJM 366:745-755, Case 6-2012, 2012
Fingolimod-Associated Macular Edema
Neurol 78:672-680, Jain,N. and Bhatti,M.T., 2012
Update on the Pathophysiology and Management of Idiopathic Intracranial Hypertension
JNNP 83:488-494, Biousse,V.,et al, 2012
CNS Involvement at the Onset of Primary Hemophagocytic Lymphohistiocytosis
Neurol 78:1150-1156, Deiva,K.,et al, 2012
Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
NEJM 366:1000-1009, Comi,G.,et al, 2012
Susceptibility-Weighted MR Imaging for Diagnosis of Capillary Telangiectasia of the Brain
AJNR 33:715-720, El-Koussy,M.,et al, 2012
Acute Symptomatic Seizures
The Neurologist 18:109-119, Beleza,P., 2012
Central Nervous System Neuronal Surface Antibody Associated Syndromes: Review and Guidelines for Recognition
JNNP 83:638-645, Zuliani,L.,et al, 2012
Clinicopathologic Conference, Neurocysticercosis Involving the Cerebral Ventricles and Spinal Meninges
NEJM 366:1924-1934, Case 15-2012, 2012
Autoimmune Epilepsy
Arch Neurol 69:582-593,565, Quek, A.M.L.,et al, 2012
Early Diffusion MR Imaging Findings and Short-Term Outcome in Comatose Patients wtih Hypoglycemia
AJNR 33:904-909, Johkura, K.,et al, 2012
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
NEJM 366:1870-1880,1938, Bloomgren, G.,et al, 2012
Clinicopathologic Conference, Glioblastonoma, WHO grade IV of IV, with Methylation of the MGMT Promoter
NEJM 366:2112-2120, Case 17-2012, 2012